BofA raises Progressive stock price target to $312 on buybacks By Investing.com

BofA Securities raised Progressive’s price target to $312 from $298 and reiterated Buy, citing upside potential and dividend support despite a March EPS of $1.55 versus its $1.62 forecast. Progressive also reported Q1 net income up 10% to $2.82 billion, net premiums written up 6% to $23.64 billion, and common EPS up 10% to $4.80. Analyst views remain mixed, with targets ranging from $190 to $247, but the overall setup is constructive on earnings momentum and buyback assumptions.

Analysis

Progressive is still behaving like the highest-quality compounder in P&C, but the interesting signal is not the headline earnings beat/miss — it is the continuing compression in operating expense intensity. If that trend reflects lower paid acquisition or flatter staffing rather than temporary timing noise, the market may be underestimating how much incremental underwriting profit can expand once claims volatility normalizes. That makes the setup less about near-term EPS and more about the durability of the company’s cost advantage versus other auto writers.

The second-order effect is on the competitive set: if Progressive can defend growth while spending less on distribution, competitors with weaker brand efficiency will have to either sacrifice margin or chase share with higher acquisition spend. That tends to widen the gap between the scale leaders and everyone else in personal lines, especially over the next 2-4 quarters as pricing discipline and policy count growth diverge. In that context, the market’s tendency to treat all large insurers as a rate-cycle trade looks too blunt.

The main risk is that margin leverage is being extrapolated off a period where prior-period development and calendar effects are helping the optics. If claims severity re-accelerates or if growth requires a re-step-up in advertising, the multiple can compress quickly because the stock already embeds a premium quality narrative versus peers. The key watch item over the next 1-2 reporting cycles is whether expense ratio improvement persists without sacrificing policy count momentum.

Contrarian take: the upside may be less about the target-price math and more about a re-rating as investors rediscover how scarce persistent underwriting efficiency is in insurance. If the market starts rewarding normalized combined-ratio stability rather than just premium growth, Progressive can continue to out-earn consensus even without heroic top-line acceleration. That makes any pullback on a noisy month a better entry than chasing after a positive analyst revision cycle.

Key Decisions for Investors

• Long PGR on weakness over the next 1-3 weeks; use pullbacks tied to any claims-volatility headline as entry, targeting a 6-10% move over 3-6 months if expense ratio improvement proves sticky.
• Pair trade: long PGR / short a lower-quality auto insurer basket for 1-2 quarters to express widening underwriting-efficiency dispersion; stop if PGR expense ratio reverts above the recent trend.
• Sell PGR downside puts 3-6 months out on modest dips to monetize elevated implied volatility while keeping upside exposure; best if you want to own the name but think the near-term newsflow is noisy.
• Avoid shorting MS solely on the article; the signal is idiosyncratic to property/casualty efficiency rather than a broad read-through to brokers or diversified financials.
• For traders, consider a tactical PGR call spread into the next earnings window if shares consolidate; risk/reward is favorable if the market continues to reward margin resilience over headline growth.